Otto Dawn Parsell 4
4 · Tricida, Inc. · Filed May 7, 2020
Insider Transaction Report
Form 4
Tricida, Inc.TCDA
Otto Dawn Parsell
Sr VP, Clinical Development
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2020-05-05−798→ 5,020 totalExercise: $1.68Exp: 2026-11-02→ Common Stock (798 underlying) - Exercise/Conversion
Common Stock
2020-05-05$1.68/sh+798$1,341→ 1,053 total - Sale
Common Stock
2020-05-05$30.05/sh−798$23,980→ 255 total - Exercise/Conversion
Common Stock
2020-05-05$2.39/sh+452$1,080→ 707 total - Sale
Common Stock
2020-05-05$30.31/sh−452$13,700→ 255 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-05-05−452→ 16,823 totalExercise: $2.39Exp: 2027-09-13→ Common Stock (452 underlying)
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2019.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.98 to $30.12, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) and (3) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.12 to $30.45, inclusive.
- [F4]This option vested 25% on October 1, 2017, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.
- [F5]This option vests 25% on September 1, 2018, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.